BioSpace News Archive

A dysphagia diet emphasizes the variety of meals and drinks that are easier and safer for patients to swallow.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global wireless portable medical devices market is anticipated to grow at 11% CAGR between 2021 and 2031 to reach valuation of US$ 33 Bn by 2031.The market was valued at US$ 15 Bn in 2020.

ANGLE plc, a world-leading liquid biopsy company, is pleased to announce that the Institute of Oncology, Ljubljana, Slovenia has published favourable results from a preliminary study in metastatic breast cancer patients.

Seagen Inc., a world leader and pioneer in antibody-drug conjugate therapies, and RemeGen Co., Ltd., a leading innovative biopharmaceutical company in China, announced that the two companies have entered into an exclusive worldwide licensing agreement to develop and commercialize disitamab vedotin, a novel HER2-targeted ADC.

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 353 owned and/or operated outpatient imaging centers, reported financial results for its second quarter of 2021.

Ra Medical Systems, Inc. announces that it will report second quarter 2021 financial results after market close on Monday, August 16, 2021.

Voyager Therapeutics, Inc., a gene therapy company developing life-changing treatments and next-generation platform technologies, introduced new programs in Huntington’s disease, a monogenic form of ALS, spinal muscular atrophy, and diseases linked to GBA1 mutations, all powered by its proprietary AAV capsids that have demonstrated superior transgene expression in the brain compared to AAV9 delivery in non-human primates.

Small Pharma Inc., a neuropharmaceutical company focused on psychedelic-assisted therapies, announced that Peter Rands, Chief Executive Officer, and Dr. Carol Routledge, Chief Medical and Scientific Officer, will present at Canaccord Genuity’s 41st Annual Growth Conference on Tuesday, August 10, 2021.

Ginkgo Bioworks, Inc. announced that it will host a presentation reviewing results for the first six months of 2021 after the market closes on Wednesday, August 18, 2021, beginning at 4:30 p.m. ET.

Sutro Biopharma, Inc., a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, announced the appointment of Jane Chung to the newly-created position of Chief Commercial Officer, effective August 9, 2021.